
@ShahidNShah
Federal officials are proposing an expedited pathway for Medicare coverage of new medical technologies. In a notice posted in the Federal Register, the Centers for Medicare & Medicaid Services (CMS) is proposing a voluntary Transitional Coverage for Emerging Technologies (TCET) pathway for designated Breakthrough Devices. Officials say the new pathway, developed in a partnership with the Agency for Healthcare Research and Quality (AHRQ), should speed up the process to bring new treatments to Medicare beneficiaries while ensuring those treatments still meet rigorous review guidelines.
The Centers for Medicare & Medicaid Services (CMS) have introduced a voluntary Transitional Coverage for Emerging Technologies (TCET) pathway, as outlined in a notice published in the Federal Register. This pathway, established in collaboration with the Agency for Healthcare Research and Quality (AHRQ), aims to expedite Medicare coverage of designated Breakthrough Devices. By implementing this pathway, officials anticipate accelerated access to novel treatments for Medicare beneficiaries, while upholding stringent review standards to ensure treatment efficacy and safety.
Continue reading at healthleadersmedia.com
ASCs are tightly regulated medical facilities. They must comply with numerous state and federal laws governing their operations, billing, and reimbursement. Staying updated on healthcare regulations …
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Mar 3, 2025 at 1:39pm